- Home
- CDNA vs OCFC Comparison
CDNA vs OCFC Comparison
Compare CDNA & OCFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDNA
- OCFC
- Stock Information
- Founded
- CDNA 1998
- OCFC 1902
- Country
- CDNA United States
- OCFC United States
- Employees
- CDNA N/A
- OCFC N/A
- Industry
- CDNA Medical Specialities
- OCFC Major Banks
- Sector
- CDNA Health Care
- OCFC Finance
- Exchange
- CDNA Nasdaq
- OCFC Nasdaq
- Market Cap
- CDNA 1.1B
- OCFC 1.1B
- IPO Year
- CDNA 2014
- OCFC 1996
- Fundamental
- Price
- CDNA $22.70
- OCFC $19.15
- Analyst Decision
- CDNA Buy
- OCFC Hold
- Analyst Count
- CDNA 8
- OCFC 4
- Target Price
- CDNA $26.43
- OCFC $21.00
- AVG Volume (30 Days)
- CDNA 851.0K
- OCFC 287.7K
- Earning Date
- CDNA 02-26-2025
- OCFC 01-23-2025
- Dividend Yield
- CDNA N/A
- OCFC 4.20%
- EPS Growth
- CDNA N/A
- OCFC N/A
- EPS
- CDNA N/A
- OCFC 1.74
- Revenue
- CDNA $312,775,000.00
- OCFC $380,971,000.00
- Revenue This Year
- CDNA $19.85
- OCFC N/A
- Revenue Next Year
- CDNA $11.34
- OCFC $5.39
- P/E Ratio
- CDNA N/A
- OCFC $11.00
- Revenue Growth
- CDNA 5.26
- OCFC N/A
- 52 Week Low
- CDNA $7.42
- OCFC $14.03
- 52 Week High
- CDNA $34.84
- OCFC $21.87
- Technical
- Relative Strength Index (RSI)
- CDNA 50.19
- OCFC 58.36
- Support Level
- CDNA $21.09
- OCFC $18.41
- Resistance Level
- CDNA $25.95
- OCFC $19.30
- Average True Range (ATR)
- CDNA 1.67
- OCFC 0.47
- MACD
- CDNA 0.04
- OCFC 0.19
- Stochastic Oscillator
- CDNA 41.96
- OCFC 92.50
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.
About OCFC OceanFirst Financial Corp.
OceanFirst Financial Corp is engaged in the banking sector of the United States. It conducts the business of attracting retail and business deposits and investing them in loans, consisting of single-family, owner-occupied residential mortgage loans, and commercial real estate loans. The company's sole segment deals with the delivery of loan and deposit products to customers. The bank's revenues are derived principally from interest on its loans, and to a lesser extent, interest on its investment and mortgage-backed securities. The rest of its income is dependent on bank card services and wealth management services.